Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Pui

Showing results (61-70 of 414) with videos related to

Pageof 42
Sort By:
Leukemia|September 14, 1999
Significance of the TEL-AML fusion gene in childhood AMLJ E Rubnitz, J R Downing, C H Pui
Leukemia|November 1, 1991
Raised plasma methotrexate concentrations following intrathecal administration in children with renal dysfunctionR E Gregory, C H Pui, W R Crom
Blood|July 13, 2000
Biological and therapeutic aspects of infant leukemiaA Biondi, G Cimino, R Pieters, et al.
Leukemia|October 6, 2001
Recombinant urate oxidase (rasburicase) in the prevention and treatment of malignancy-associated hyperuricemia in pediatric and adult patients: results of a compassionate-use trialC H Pui, S Jeha, D Irwin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Retrieval therapy for isolated CNS relapse in childhood acute lymphoblastic leukemiaG K Rivera, R C Ribeiro, C H Pui
Leukemia & Lymphoma|July 27, 2016
Pre-B-Cell Acute Lymphoblastic Leukemia in ChildhoodW M Crist, A J Carroll, C H Pui
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
The epipodophyllotoxins: both sides of the coinG K Rivera, C H Pui, W M Crist
Therapeutic Drug Monitoring|October 21, 1998
Pharmacodynamic monitoring of cancer chemotherapy: childhood acute lymphoblastic leukemia as a modelC R Yates, C H Pui, W E Evans
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
MTX clearance is more important for intermediate-risk ALLW E Evans, M J Schell, C H Pui
Advances in Experimental Medicine and Biology|September 29, 1999
Defining the optimal dosage of methotrexate for childhood acute lymphoblastic leukemia. New insights from the lab and clinicW E Evans, C H Pui, M V Relling
Pageof 42

Showing results (61-70 of 414) with videos related to

Sort By:
Pageof 42
Leukemia|September 14, 1999
Significance of the TEL-AML fusion gene in childhood AMLJ E Rubnitz, J R Downing, C H Pui
Leukemia|November 1, 1991
Raised plasma methotrexate concentrations following intrathecal administration in children with renal dysfunctionR E Gregory, C H Pui, W R Crom
Blood|July 13, 2000
Biological and therapeutic aspects of infant leukemiaA Biondi, G Cimino, R Pieters, et al.
Leukemia|October 6, 2001
Recombinant urate oxidase (rasburicase) in the prevention and treatment of malignancy-associated hyperuricemia in pediatric and adult patients: results of a compassionate-use trialC H Pui, S Jeha, D Irwin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Retrieval therapy for isolated CNS relapse in childhood acute lymphoblastic leukemiaG K Rivera, R C Ribeiro, C H Pui
Leukemia & Lymphoma|July 27, 2016
Pre-B-Cell Acute Lymphoblastic Leukemia in ChildhoodW M Crist, A J Carroll, C H Pui
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
The epipodophyllotoxins: both sides of the coinG K Rivera, C H Pui, W M Crist
Therapeutic Drug Monitoring|October 21, 1998
Pharmacodynamic monitoring of cancer chemotherapy: childhood acute lymphoblastic leukemia as a modelC R Yates, C H Pui, W E Evans
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
MTX clearance is more important for intermediate-risk ALLW E Evans, M J Schell, C H Pui
Advances in Experimental Medicine and Biology|September 29, 1999
Defining the optimal dosage of methotrexate for childhood acute lymphoblastic leukemia. New insights from the lab and clinicW E Evans, C H Pui, M V Relling
Pageof 42